RESEARCH > Funding Opportunities


Funding Opportunities

The AUA is committed to supporting urologic research through funding, advocacy and scholarly exchange. Through our Research Scholars Program and other internal and external funding awards, the AUA and Urology Care Foundation have been providing support to young urology researchers for 40 years!

Award Programs for Researchers

Research Scholars Program

One- and two-year awards are available in 2016 for eligible MD and PhD researchers interested in pursuing careers in urologic research. Recipients receive $40,000 annually and the sponsoring institution provides matching funds.

Learn more about this program.

Rising Stars in Urology Research Awards

Awards are available for 2015! Applicants are Board-certified or -eligible urologists who have successfully competed for a new externally-funded, peer-reviewed career development award (e.g., K07/K08/K23 awards from the National Institute of Health (NIH), or career development-type grants from the Department of Defense, American Cancer Society or others). This Program provides up to five years of supplemental salary support to career development Awardees to ensure their research salary compensation is competitive with other academic urology faculty. Currently, the salary supplementation starts at $28,000 and increases each award year based on the following schedule: Year 2: $33,000; Year 3: $40,000; Year 4: $46,000; and Year 5: $52,000.

Learn more about this program.

Award Program for Residents

Russell Scott, Jr., MD Urology Residency Research Award Program

The Russell Scott, Jr., MD, Urology Residency Research Award is designed to fund a urology resident for a period of one year while the resident fulfills their obligation for research training. Recipients receive a $40,000 stipend that must also be matched by the participating institution. Applicants must be enrolled in an accredited urology resident program and willing to spend at least 80 percent of their total time on the research project.

Learn more about this program.

Fellowships for Medical Students

Arkansas Urologic Society Summer Medical Student Fellowship Program

The Urology Care Foundation and the Arkansas Urologic Society is proud to provide the Arkansas Urologic Society Summer Medical Student Fellowship Program, designed to encourage medical students to join the field of urology through a summer fellowship program. This program is made possible through the support of the Arkansas Urologic Society Research Fund.

Learn more about this program.

Herbert Brendler, MD, Summer Medical Student Fellowship Program

The Urology Care Foundation is proud to provide the Herbert Brendler, MD, Summer Medical Student Fellowship Program, designed to encourage medical students to join the field of urology through a summer fellowship program. This program is made possible through the support of the Herbert Brendler, MD, Research Fund and the Brendler Family. Each awardee receives a $3,000 stipend to cover the two month mentored research project, and the sponsoring institution ensures that the awardee receives adequate research support.

Learn more about this program.

AUA Data Grants

Beginning in 2014, the AUA completed the newly established Data Grant. The AUA Data Grant promotes novel and methodologically rigorous analyses that inform policymakers, payers, the urology community, other healthcare providers and the public about key issues in urological care delivery.

The AUA is particularly interested in supporting population-based, data-driven, specialty generalizable studies using electronic health records, data maintained by the AUA (including population-based survey data, CMS administrative and claims data, the ABU certification file, and the AUA membership database) or other data sources already available to investigators.

Learn more about AUA Data Grants.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

2015 Diabetic Complications Consortium (DiaComp) Pilot & Feasibility Program
Click to Expand

About the Program

The NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is soliciting applications for its annual Pilot and Feasibility Program. This program solicits and funds small Pilot and Feasibility (P&F) projects in high impact areas of complications research. Specifically, this program aims to support discovery (hypothesis generating) and innovative (high risk/ high reward) research that is increasingly difficult to support through standard NIH mechanisms. Basic, translational and clinical research proposals are encouraged. Research involving human subjects is limited to observational studies with non-invasive or minimally invasive testing and must have IRB approval that includes the collection and use of human samples for research purposes. Interventional clinical trials are beyond the scope of this program. Awards are expected to prepare the applicant(s) to submit a future investigator initiated project (e.g. NIH R01). Lower priority will be given to applicants who have received DiaComp support in the past three years.

Application Deadline

Applications of 5 pages requesting up to $100,000 for one year are due Friday, May 8, 2015.


NIDDK Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21)
Click to Expand

About the Program

This Funding Opportunity Announcement (FOA) from the National Institute of Diabetes and Digestive and Kidney Disease is to support Exploratory/Developmental Research Grants (R21) that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to urologic disorders research. Studies should address important clinical and translational questions that are potentially of high clinical and public health impact. It is anticipated that some projects supported by these grants may lead to full-scale clinical studies including diagnostic strategies, epidemiological studies, or randomized clinical trials of prevention, diagnosis or treatment of urologic disorders.

Application Deadline

Applications will be accepted beginning May 16, 2015. Standard dates apply by 5 p.m., local time of applicant organization.

Contact Information

Please direct questions to Ziya Kirkali, MD.


NIDDK Big Data Participation
Click to Expand

About the Program

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is participating, effective immediately, in the following Funding Opportunity Announcement (FOA): RFA-CA-15-006 "Big Data to Knowledge (BD2K) Advancing Biomedical Science Using Crowdsourcing and Interactive Digital Media (UH2)."

The purpose of this Big Data to Knowledge funding opportunity announcement is to support the development of new or significantly adapted interactive digital media that engages the public, experts or non-experts, in performing some aspect of biomedical research via crowdsourcing. To be responsive to this FOA, each application is expected to pose a challenging biomedical research problem and propose the development of engaging interactive digital media that incorporates crowdsourcing as a fundamental component of how the problem is solved. The biomedical research problem should be amenable to one or more human computation approaches, as the users must be active participants in the analysis and/or interpretation of data, rather than acting primarily as data collectors or sources of data.

The Letter of Intent is due May 3, 2015, and the application due date is June 3, 2015.


New Funding Opportunity for MAPP Network Basic/Translational Science
Click to Expand

About the Program

The Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network, supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), invites research grant applications to conduct fundamental basic and translational research focused on urologic chronic pelvic pain syndrome (UCPPS).

The NIDDK has allocated up to $2 million to solicit basic and translational studies from investigators NEW to the MAPP Network that will be conducted in collaboration with the existing MAPP Network and in support of the Network's goals of informing future clinical investigations and ultimately improving clinical management of UCPPS patients.

Applications may request up to $500,000 and will be supported through sub-contracts to the MAPP Network's Data Coordination Core (DCC) at the University of Pennsylvania.

Application Deadline

The application receipt date is June 15, 2015.

Contact Information

For additional information and to discuss development of proposed research studies, applicants should contact the NIDDK and the MAPP Network DCC (contact information below).

Chris Mullins, PhD
NIH Project Scientist for the MAPP Network
Director of Basic Cell Biology Programs
Division of Kidney, Urologic and Hematologic Diseases
Phone: 301-451-4902
Fax: 301-480-3510
Email: mullinsC@mail.nih.gov

Nancy A. Robinson-Garvin, PhD
MAPP Network Data Coordinating Core (DCC) Project Manager
Senior Research Investigator
Phone: 215-573-4421
Fax: 215-573-6262
Email: narobins@mail.med.upenn.edu


NIDDK Research Education Program Grants (R25)
Click to Expand

About the Program

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDDK Research Education R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish this goal, three funding opportunity announcements have been released:

 

Application Deadline

Standard dates apply for all, by 5 p.m. local time of applicant organization.

Contact Information

Please contact Arthur Castle, PhD with questions.


NIDDK Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01)
Click to Expand

About the Program

The purpose of this funding opportunity announcement (FOA) is twofold: (1) to stimulate basic and mechanistic science that facilitates the development of effective probiotics or pre-/probiotic combinations of relevance to human health and disease; and (2) determine biological outcomes for the evaluation of efficacy of pre/probiotics in appropriate test systems and animal models. This FOA encourages basic and mechanistic studies using in vitro, in vivo, ex vivo, and in silico models that focus on prebiotic/probiotic strain selectivity, interaction, and function. It will also encourage inter and multidisciplinary collaborations among scientists in a wide range of disciplines including nutritional science, immunology, microbiomics, genomics, other '-omic' sciences, biotechnology, and bioinformatics.

Application Deadline

Standard dates apply by 5 p.m. local time of applicant organization.

Contact Information

Please contact Dr. Peter J. Perrin with questions.


NIH-Funded K12 Post-Doctoral Training in Benign Urological Research
Click to Expand

About the Program

Programs that provide training of post-doctoral candidates in benign urological research are available at Baylor College of Medicine, Case Western Reserve University, Duke University, the University of California-San Francisco, and the University of Wisconsin. The overarching goal of these programs is to prepare individuals to acquire the skills necessary to develop a career that includes development of a successful program of independent research in benign urology. A broad array of opportunities is available, ranging from clinical to basic research.

Contact Information

Please contact individual programs using the following information to learn more about the application process and opportunities available at the various institutions.

Baylor College of Medicine
Dr. Dolores J. Lamb – dlamb@bcm.edu

Case Western Reserve University
Dr. Firouz Daneshgari – fxd22@case.edu

Duke University
Dr. Cindy L. Amundsen – cindy.amundsen@duke.edu

The University of California-San Francisco
Dr. Laurence S. Baskin – Laurence.Baskin@ucsf.edu

The University of Wisconsin
Dr. Dale E. Bjorling – bjorling@wisc.edu
Dr. Wade Bushman – bushman@urology.wisc.edu


NIDDK Notice to Extend PAR—12-047 "NIDDK Education Grants (R25)"
Click to Expand

About the Program

The purpose of this Notice is to extend PAR-12-047, "NIDDK Education Program Grants (R25)." This funding opportunity announcement (FOA) encourages Research Education (R25) grant applications from applicant organizations that propose to create educational opportunities for undergraduate students, graduate students, and postdoctoral fellows in areas of biomedical or behavioral research of particular interest to the NIDDK, while fostering the career development of these students and fellows. The structure of the educational opportunity can include an intensive summer research program, a curriculum-based program or a combination of both experiences. The NIDDK is especially interested in attracting students and postdoctoral fellows from scientific disciplines underrepresented in disease-oriented biomedical research, such as engineering, informatics, computer science, and computational sciences, to encourage them to apply their expertise to research relevant to diabetes and other endocrine and metabolic diseases; digestive and liver diseases; nutrition; obesity research and prevention; and kidney, urologic and hematologic diseases.

Application Deadline

The current expiration date is January 8, 2015. The new expiration date is May 8, 2015. All other aspects of the Funding Opportunity Announcement (FOA) remain the same.

Contact Information

Please contact Tracy L. Rankin, PhD at rankint@mail.nih.gov for more information.


NIDDK Notice to Extend R21 in Urology Research
Click to Expand

About the Program

The purpose of this Notice is to extend PAR-11-352 "Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Diseases (R21)" which supports Exploratory/Developmental Research Grants that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to kidney or urologic disease research.

Application Deadline

The current expiration date is January 8, 2015. The new expiration date is May 8, 2015.

Contact Information

Please contact Ziya Kirkali, MD at ziya.kirkali@nih.gov for more information.


National Cancer Institute (NCI)

NCI Transition Career Development Award (K22)
Click to Expand

About the Program

The objective of the National Cancer Institute (NCI) Transition Career Development Award (K22) is to provide support to mentored, non-independent investigators in transitioning to their first independent tenure-track faculty cancer research positions, or their equivalent, with an enhanced probability of success for obtaining independent National Institutes of Health (NIH) or other research project grant support. Candidates in mentored, non-independent cancer research positions may apply, and if successful, must obtain tenure-track faculty, or equivalent, positions, and NCI approval before awards will be issued.

The NCI K22 award will provide up to 3 years of support for the most promising and exceptionally talented mentored, non-independent investigators. This period of support is to allow the investigator to work towards establishing his/her own independent research program and to prepare an application for research grant support (R01 or equivalent).

Application Deadline

Applications will be accepted beginning January 12, 2015. Standard due dates apply.

Contact Information

Please contact Sonia B. Jakowlew, PhD with scientific and/or research inquiries.


Agency for Healthcare Research and Quality (AHRQ)

AHRQ Small Research Grant Program (R03)
Click to Expand

About the Program

This Funding Opportunity Announcement encourages Small Research Grant (R03) applications, and expresses Agency for Healthcare Research and Quality (AHRQ) priority areas of interest for ongoing small research projects. The R03 grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

Small research (R03) grants provide flexibility for initiating studies which are generally for preliminary or short-term projects. These grants are non-renewable. The AHRQ small grant is a mechanism for supporting discrete, well-defined projects that realistically can be completed within two years (or less) within the budget constraints of the mechanism. Because the research strategy section of the application is limited to 6 pages, an R03 grant application may not contain the same level of detail as that found in an R01 application. Accordingly, appropriate justification for the proposed work can be provided through literature citations, data from other sources, or from investigator-generated data. Preliminary data are not required, particularly in applications proposing pilot or feasibility studies.

Application Deadline

Applications will be accepted beginning May 16, 2015. Standard dates apply by 5 p.m., local time of applicant organization.

Contact Information

Please direct questions regarding specific program matters to the AHRQ staff listed at: www.ahrq.gov/funding/priorities-contacts/contacts/index.html.


AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Clinical Investigator Award (K08) PA-13-180
Click to Expand

About the Program

The primary purpose of the AHRQ PCOR Mentored Clinical Investigator Award (K08) program is to prepare qualified individuals for careers utilizing complex comparative effectiveness research (CER) methods to clinical and health systems PCOR issues, involving stakeholders, as appropriate, in the design, execution, and dissemination of the research.

Application Deadline

Standard due dates apply, by 5 p.m. local time of applicant organization.

Contact Information

Please contact Kay Anderson, PhD at Kay.Anderson@ahrq.hhs.gov with any questions.


AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Research Scientist Development Award (K01) PA-13-181
Click to Expand

About the Program

The primary purpose of the AHRQ PCOR Mentored Research Scientist Development Award (K01) program is to prepare qualified individuals for careers utilizing complex comparative effectiveness research (CER) methods to clinical and health systems PCOR issues, involving stakeholders, as appropriate, in the design, execution,and dissemination of the research.

Application Deadline

Standard due dates apply, by 5 p.m. local time of applicant organization.

Contact Information

Please contact Kay Anderson, PhD at Kay.Anderson@ahrq.hhs.gov with any questions.


Disseminate Patient-Centered Outcomes Research (PCOR) through Clinical Decision Support (U19)
Click to Expand

About the Program

The Agency for Healthcare Research and Quality (AHRQ) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) that will promote the dissemination of patient-centered outcomes research (PCOR) findings through clinical decision support (CDS).

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in the Winter 2014/15 with an expected application due date in Spring 2015. This FOA will utilize the Research Program Cooperative Agreement (U19) activity code.

Application Deadline

Spring 2015

Contact Information

Please note that applications are not being solicited at this time. Please direct all inquiries to Edwin A. Lomotan, MD.


National Institutes of Health (NIH)

New BD2K RFA – Supporting Biomedical Data Repository Interoperability
Click to Expand

About the Program

TThe National Institutes of Health (NIH) is excited to announce a new BD2K funding opportunity: Supplements to Support Interoperability of NIH Funded Biomedical Data Repositories (Admin Supp) PA-15-144. The NIH is accepting administrative supplement requests to support projects that will establish or improve interoperability among NIH funded biomedical data repositories. Improved interoperability is expected to lead to increased efficiency of repositories’ operations and cost reductions, which are significant factors of the NIH’s long-term sustainability plans for the biomedical data repositories.

Each supplement request should be associated to a collaborative project consisting of a biomedical data repository supported by an active NIH-funded parent grant, and one or more collaborating sites that together implement the interoperability goals of this FOA. The collaborating sites may be other biomedical data repositories, or may provide computational tools and data standards, or perform other activities that facilitate interoperability among data repositories. Supplement requests will only be accepted from active NIH-funded parent grants that primarily support biomedical data repositories with an overall annual budget above $500,000 in direct costs.

Application Deadline

The application receipt date is April 20, 2015.

Contact Information

Please direct all inquiries to the BD2K program contact Valentina Di Francesco AND to the Program Officer listed on the Notice of Award of the parent award.


Additional Funding Opportunities

2015 PCF Young Investigator Award
Click to Expand

About the Program

The Prostate Cancer Foundation (PCF) Young Investigator Awards are three (3) years in duration and provide $75,000 per year. The award funds may be used flexibly to advance the career and research efforts of the awardee. Every PCF Young Investigator is required to be under the direct supervision of a mentor.

Applicants should be within six-years following completion of a professional degree or clinical training such as MD, PhD, DSc, MD-PhD or equivalent and hold the title of Senior Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor, or equivalent. Applicants should have received no more than $200,000 in current direct research funding from all sources including institutional funds. Investigators who have specifically received young investigator research support from the NCI, NIH, or DoD are still qualified and very much encouraged to apply. Young Investigator awardees are required to attend the Annual PCF Scientific Retreat and Young Investigator Day, typically held in October, throughout the duration of their award.

Application Deadline

Please refer to the RFA for details on eligibility requirements and application submission guidelines. The online application submission form will go live at pcf.smartsimple.com on April 17, 2015. The deadline for submission is June 3, 2015. Submit the online application at pcf.smartsimple.com.


Association for Surgical Education
Click to Expand

About the Program

The Association for Surgical Education Foundation was established by the Association for Surgical Education in 1993 to raise and disseminate funds in support of innovative research and education projects and programs that advance surgical education in North America.

Through its Center for Excellence in Surgical Education, Research, and Training (CESERT) grant program, the foundation is accepting applications for patient care research projects aimed at developing and testing content methods that will yield improvement in patient care surgery; developing and validating new methods of performance assessment across competency domains required for quality patient care; improving surgical education programs for medical students; enhancing professional development, retention, and reward of faculty and residents who teach and mentor learners in surgery; and/or testing new methods, resources, and programs for improving performance and accountability relevant to the administration of surgical education. Research studies could include teaching techniques, performance evaluation methods, instructional and curriculum design, and educational program design.

The maximum amount to be awarded for any CESERT grant proposal, regardless of length of study, is $25,000.

To be eligible, applicants must be an active ASE member or a member of another national surgical association. (Association members will be given priority consideration.) If a non-ASE member wishes to apply for a grant, the non-member investigator must work in collaboration with, or have their project endorsed by, an ASE member.

Application Deadline

The application deadline is June 1, 2015. Review Complete RFP


Damon Runyon-Rachleff Innovation Award
Click to Expand

About the Program

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.

The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.

The initial award will be for two years, $150,000 per year ($300,000 total) with the opportunity for up to two additional years of funding (up to four years total for $600,000). Continued support for years three and four will be granted to those awardees who demonstrate significant progress on their proposed research during years one and two of the award. The Innovation Award funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator’s salary, salaries for professional and technical personnel, special equipment, supplies and other miscellaneous items required to conduct the proposed research.

Application Deadline

Applications are due July 1, 2015.

Contact Information

For more information visit the Damon Runyon Cancer Research Foundation.


Movember/Prostate Cancer Foundation
Click to Expand

About the Program

The Prostate Cancer Foundation (PCF) is pleased to announce a request for applications for Movember-PCF Challenge Awards for investigations of metastatic, lethal prostate cancer. These awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired. At least six (6) Challenge Awards from U.S.-based teams will be funded by money raised in the U.S. by Movember, and given the prestigious designation of 'Movember-PCF Challenge Awards'.

PCF Challenge Awards:

  • Team science awards are composed of at least three (3) investigators, including one young investigator (see PCF Challenge Award Team requirements below).
  • Support large-scale research projects concerning metastatic, lethal prostate cancer over a duration of two years.
  • Provide up to a total of $1 million per team.
  • Cover direct research costs only.

Research proposals in the following topic areas are preferred:

  • New systemic treatments for metastatic, lethal prostate cancer including those targeting the currently 'undruggable'.
  • First-in-field research on new targets in metastatic, lethal prostate cancer systemic treatment.
  • Mechanisms of resistance to current and investigational drugs targeting the androgen receptor and androgen axis, immune system and chemotherapy.
  • Correlative research around either clinical trials of novel agents or strategies or standard of care.
  • Developing or validating biomarkers that guide therapy in patients or further our understanding of the mechanism by which therapies work.
  • Tumor microenvironment signaling related to cancer progression including the immune component are topic areas we strongly encourage.
  • Immunotherapy for the treatment of metastatic, lethal prostate cancer.
  • New bioinformatics technologies for analysis of genomic data.

Application Deadline

The online application submission portal will go live at pcf.smartsimple.com on March 24, 2015. The deadline for application submission is April 30, 2015, 11:59 p.m., PST.

Contact Information

Please direct questions to applications@pcf.org.


Travel Awards

Travel awards may be available on a competitive basis to Young Investigators and Trainees interested in attending AUA Office of Research events. Individuals will be reimbursed for expenses related to travel and lodging costs associated with attendance in accordance with the Urology Care Foundation guidelines.

* Young investigators are defined as an MD or PhD, or having an equivalent doctoral-level degree, who are actively engaged in research and within 10 years of completion of a residency or fellowship, or from completing requirements for a PhD at the date of application.

Please check back for information related to currently available travel awards.

ADVERTISEMENT

ADVERTISEMENT
Donate
Contact
Press/Media
Sections
Term of Use
Site Map


ADVERTISEMENT